Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 18Neoplasms 18Breast Neoplasms 16Colorectal Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Lung Neoplasms 10Urinary Bladder Neoplasms 6Squamous Cell Carcinoma of Head and Neck 6Hematopoietic and Lymphatic System Neoplasm 6Hematologic Neoplasms 6Ovarian Neoplasms 5Neoplasm Metastasis 5Triple Negative Breast Neoplasms 4Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Multiple Myeloma 3Mouth Neoplasms 3Hematopoietic and Lymphoid System Neoplasm 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Renal Cell 3Sarcoma 2Radiodermatitis 2Peritoneal Neoplasms 2Pathologic Complete Response 2Parotid Neoplasms 2Motor Activity 2Melanoma 2Malignant Solid Neoplasm 2

Interventions

pembrolizumab 1lenvatinib 1enfortumab vedotin 1abemaciclib 1Tablets 1Standard of Care 1Radiosurgery 1Protons 1Nivolumab 1Epirubicin 1Combined Modality Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Adenoid Cystic × Standard of Care × Clear all
NCT04883671 2025-09-23

Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial

Dana-Farber Cancer Institute

Phase NA Recruiting
32 enrolled

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡